Rhabdomyosarcoma

• FDA approval · 2021-01-14
  FDA Approved: VINCRISTINE SULFATE — Supplemental Application (Hospira, Inc.)

  The FDA approved a supplemental application filed by Hospira for vincristine sulfate, a generic vincristine product.

• FDA approval · 2019-05-20
  FDA Approved: DACTINOMYCIN — Original Application (XGen Pharmaceuticals DJB, Inc.)

  FDA approved the original (ANDA) application for Dactinomycin from XGen Pharmaceuticals DJB, Inc., establishing a generic version of this ch…

• FDA approval · 2017-11-09
  FDA Approved: DACTINOMYCIN — Original Application (Eugia US LLC)

  FDA approved the original ANDA for dactinomycin (generic) to Eugia US LLC, enabling generic manufacturing and distribution of this anticance…